Ethiopia

 

Interview: Prof Dr Hatem Elgabaly, CEO, RX Health Management

A serial healthcare entrepreneur who also spent five years as Egypt’s Minister of Health and Population, Prof Elgabaly is now raising a $200m healthcare fund for investment in Healthcare in Africa and is already at present proceeding with investments. We talk to him about the Egyptian and wider African markets and about his investment approach.

Interview: Ariel Beery, CEO of MobileODT – turning mobile phones into diagnostic equipment

Are mobile phones the latest in high-tech, low cost diagnostic equipment? The humble mobile is being transformed into a medical tool, and the team behind this transformation say their bolt-on device brings expert clinical diagnosis to previously inaccessible areas. We caught up with Ariel Beery, co-founder and CEO of Israel-based MobileODT - which is in the running for the HBI Best Use of Digital Award at our 2017 conference in April - about his business model.

Egyptian investor close to making acquisitions in Africa

The Egyptian investor Rx Health Management is close to committing most of its US$50m Egyptian fund and is close to making acquisitions in Africa. We speak to CEO and chairman Professor Hatem Elgabaly to find out more.

Al Borg attracts interest

Three Gulf-based private equity firms are reportedly interested in buying a minority stake in Al Borg Medical Laboratories, the largest player in Saudi Arabia. We report on Al Borg’s expansion plans.

Lancet shows the way in African labs

Dr. Peter Clarke from South African lab group Lancet laid out his pan-African expertise at our 2016 Breaking Barriers conference. What business models work in Kenya? What about Nigeria, to the other side of the continent? Most private equity houses and institutional investors are daunted by Africa, but Lancet has expanded to 11 countries in just 12 years.

Mediheal expands to Ethiopia

Kenya-based hospital operator Mediheal, which runs one hospital and five diagnostic centres (total figures) in Eldoret, Nakuru, Nairobi and Kigali is entering a Ksh100m ($1m) expansion phase in Kenya and Ethiopia. We speak to CEO Devaki Nandan Bansal.

Abraaj close to $1bn target

Abraaj is close to its $1bn target for its mammoth Global Healthcare Fund. And its ambitions are becoming clearer.

Dr Agarwal bets on Africa

Of all types of Indian healthcare operators none have been as successful in Africa as Dr Agarwal, India’s second largest eye care chain. In just five years, it has grown its African business from nothing to 30-35% of sales. So far, it has 15 clinics in Mozambique, Nigeria, Madagascar, Rwanda, Uganda, Zambia, the Seychelles and Mauritius, but it plans to open six this year and to have 40 by 2020. We talk to Dr Agarwal’s CEO S. Rajagopalan.

Interview: Dr Peter Cole, managing partner at Lancet Laboratories

South African diagnostic lab group Lancet is consolidating the African lab market, expanding into 12 countries in 12 years. We speak to managing partner, Dr Peter Cole, about the South African healthcare services market generally, the different African markets and the challenge posed by European and Indian competitors.

Find Us